InvestorsHub Logo
icon url

bas2020

08/03/23 9:14 AM

#425609 RE: Investor2014 #425603

How many and under what condition might actually improve on A2-73 is tbd


With Missling stating that the trial results were better than expected and the fact that they led with Odds Ratios to highlight the super responders, provides much hope that for many patients blarcamesine will indeed be disease-modifying. Even with a slower decline, if quality of life/health is improved, with better mood, sleep, and ability to function, it'll be an amazing therapy for many.

It'll all be revealed in due time...